Psoriasis

The Dermatologist
Dr Prussick on Managing Psoriasis Comorbidities
Psoriasis is associated with many comorbid conditions. In an interview with The Dermatologist, Ronald Prussick, MD, discusses the latest research on these comorbidities, evidence on lifestyle and treatment options that could potentially prevent or manage both psoriasis and comorbid conditions, and the importance of screening and aggressively treating psoriatic arthritis.
ALN
Can Biologic Doses Be Lowered for Patients With Stable Disease?
In a recent study, researchers investigated whether dose reduction of biologics was noninferior to usual care among patients with well-controlled plaque psoriasis.
The Dermatologist
Apremilast May Help With Biologic Fatigue
Results from a small retrospective study suggest adding apremilast to biologic therapy may be a safe and effective option for biologic fatigue among patients with psoriasis.
The Dermatologist
Metabolic Conditions Increase Likelihood of Switching or Discontinuing Biologic Treatment
In a recent study that assessed the impact of metabolic conditions on health care costs and treatment outcomes for biologics and apremilast, the researchers found patients with psoriasis and metabolic conditions had higher rates of switching and discontinuation.
The Dermatologist
Does Body Weight Affect Psoriasis Risk?
A recent nationwide population-based cohort study investigated the impact of body weight variability on the risk of developing psoriasis.

Q&A's

Dr Prussick on Managing Psoriasis Comorbidities
Back to Top